DMAC Net Income Growth
Diamedica Therapeutics Inc · Net Income Growth
DMAC Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-31.69%period ending
DMAC Quarterly Net Income YoY % (-271.14% → -31.69%)
Year-over-year change
High-resolution chart · PNG
DMAC net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -31.6924% | |
| -30.2971% | |
| -10.6329% | |
| -37.3924% | |
| -50.4005% | |
| -49.6214% | |
| -53.0711% | |
| -40.3265% | |
| -14.34% | |
| 2.2951% | |
| -37.59% | |
| -46.1589% | |
| -33.3234% | |
| -50.2851% | |
| -15.5576% | |
| 11.3333% | |
| -2.5657% | |
| 3.1474% | |
| 22.7143% | |
| -8.0489% | |
| -32.3363% | |
| -49.3608% | |
| -69.3548% | |
| -30.433% | |
| -0.2025% | |
| 25.4305% | |
| -133.5228% | |
| -363.1355% | |
| 30.6806% | |
| -459.0876% | |
| -7.9756% | |
| 41.0155% | |
| -232.4321% | |
| 55.5611% | |
| -137.3655% | |
| 4.873% | |
| -102.7904% | |
| -272.5781% | |
| 13.4317% | |
| -300.9477% | |
| -57.4563% | |
| 20.7637% | |
| 36.2809% | |
| 73.3484% | |
| 72.625% | |
| 78.1918% | |
| 37.3722% | |
| 33.0241% | |
| 43.3454% | |
| 25.4178% | |
| 59.7644% | |
| 48.9494% | |
| 15.2115% | |
| -48.9282% | |
| -55.4185% | |
| -46.4376% | |
| -68.2817% | |
| -13.22% | |
| -1.2117% | |
| -72.6524% | |
| -110.3251% | |
| -250.3815% | |
| -232.9493% | |
| -69.4321% | |
| -55.6761% | |
| 28.4108% | |
| -70.3978% | |
| 15.7088% | |
| 28.1614% | |
| -237.5535% | |
| 47.5912% | |
| -71.6215% | |
| 36.3707% | |
| -14.4951% | |
| -234.7287% | |
| -112.4191% | |
| -416.1388% | |
| 11.1092% | |
| -260.4911% | |
| -272.4112% | |
| -293.2471% | |
| -271.1351% |